A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease

por Pudi, Krishna K., Barnes, Chris N., Moran, Edmund J., Haumann, Brett, Kerwin, Edward
Publicado 2017

An Open-Label Study Evaluating the Performance of the Dose Indicator in a Metered Dose Inhaler Delivering Glycopyrrolate and Formoterol Fumarate in Patients with Moderate-to-Very S...

por Pudi, Krishna, Feldman, Gregory, Fakih, Faisal, Mack, Peter, Maes, Andrea, Siddiqui, Shahid, St. Rose, Earl, Reisner, Colin
Publicado 2019

Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD

por Crim, Courtney, Watkins, Michael L, Bateman, Eric D, Feldman, Gregory J, Schenkenberger, Isabelle, Kerwin, Edward M, Crawford, Catriona, Pudi, Krishna, Ho, Shuyen, Baidoo, Charlotte, Castro-Santamaria, Ramiro
Publicado 2019

24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD

por Reisner, Colin, Gottschlich, Gregory, Fakih, Faisal, Koser, Andras, Krainson, James, Delacruz, Luis, Arora, Samir, Feldman, Gregory, Pudi, Krishna, Siddiqui, Shahid, Orevillo, Chad, Maes, Andrea, St. Rose, Earl, Martin, Ubaldo
Publicado 2017